Rankings
▼
Calendar
ONC (BeOne Medicines Ltd.) Stock Financials & Earnings | Market Cap Arena
ONC
BeOne Medicines Ltd.
Mkt Cap
$33B
Healthcare
·
Medical - Pharmaceuticals
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$5.3B
Net Income (TTM)
$287M
EPS (TTM)
$21.52
Free Cash Flow (TTM)
$613M
Gross Margin
87.5%
Op. Margin
8.4%
Net Margin
5.4%
FCF Margin
11.5%
P/S Ratio (TTM)
6.2x
P/E Ratio (TTM)
114.7x
YoY Rev Growth
+40.2%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$448M
$366M
-$371M
Q2 23
$595M
$499M
-$319M
Q3 23
$781M
$685M
-$134M
Q4 23
$634M
$529M
-$384M
Q1 24
$752M
$627M
-$261M
Q2 24
$929M
$791M
-$107M
Q3 24
$1.0B
$831M
-$120M
Q4 24
$1.1B
$967M
-$79M
Q1 25
$1.1B
$952M
$11M
Q2 25
$1.3B
$1.2B
$88M
Q3 25
$1.4B
$1.2B
$163M
Q4 25
$1.5B
$1.4B
$185M
marketcaparena.com
Revenue Breakdown
ONC
BeOne Medicines Ltd.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
21.1x
—
Q2 23
18.2x
—
Q3 23
14.9x
—
Q4 23
13.4x
—
Q1 24
11.9x
—
Q2 24
10.6x
—
Q3 24
9.9x
—
Q4 24
8.6x
—
Q1 25
7.9x
—
Q2 25
7.2x
—
Q3 25
6.6x
480.3x
Q4 25
6.2x
114.7x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$564M
-$689M
Q2 23
-$294M
-$415M
Q3 23
-$78M
-$260M
Q4 23
-$222M
-$389M
Q1 24
-$309M
-$502M
Q2 24
-$96M
-$206M
Q3 24
$188M
$55M
Q4 24
$75M
-$17M
Q1 25
$44M
-$72M
Q2 25
$264M
$200M
Q3 25
$403M
$354M
Q4 25
$417M
$131M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$126M
Q2 23
$121M
Q3 23
$182M
Q4 23
$167M
Q1 24
$193M
Q2 24
$110M
Q3 24
$134M
Q4 24
$92M
Q1 25
$116M
Q2 25
$64M
Q3 25
$48M
Q4 25
$286M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+46.0%
+9.2%
Q2 23
+74.3%
+17.0%
Q3 23
+101.6%
+10.8%
Q4 23
+66.9%
+20.0%
Q1 24
+67.9%
+23.7%
Q2 24
+56.1%
+13.4%
Q3 24
+28.2%
+22.6%
Q4 24
+77.8%
+18.6%
Q1 25
+48.6%
+9.2%
Q2 25
+41.6%
+18.4%
Q3 25
+41.0%
+11.3%
Q4 25
+32.8%
+8.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$75M
16.8%
Q2 23
$103M
17.4%
Q3 23
$96M
12.3%
Q4 23
$93M
14.6%
Q1 24
$89M
11.8%
Q2 24
$131M
14.1%
Q3 24
$115M
11.5%
Q4 24
$108M
9.5%
Q1 25
$95M
8.5%
Q2 25
$151M
11.5%
Q3 25
$141M
10.0%
Q4 25
$757M
50.5%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$409M
$328M
Q2 23
$423M
$395M
Q3 23
$453M
$366M
Q4 23
$494M
$417M
Q1 24
$461M
$427M
Q2 24
$454M
$444M
Q3 24
$496M
$455M
Q4 24
$542M
$505M
Q1 25
$482M
$459M
Q2 25
$525M
$538M
Q3 25
$524M
$529M
Q4 25
$615M
$555M
marketcaparena.com
Revenue by Geography
All Other Countries Except China And United States Of America
China
Europe
United States
Quarter
All Other Countries Except China And United States Of America
China
Europe
United States
Q1 25
$32M
$400M
$119M
$567M
Q2 25
$36M
$433M
$152M
$694M
Q3 25
$51M
$440M
$167M
$755M
Q4 25
—
$407M
$174M
$864M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$3.5B
$294M
$3.8B
Q2 23
$3.4B
$106M
$3.5B
Q3 23
$3.1B
$107M
$3.2B
Q4 23
$3.2B
$3M
$3.2B
Q1 24
$2.8B
$0
$2.8B
Q2 24
$2.6B
$0
$2.6B
Q3 24
$2.7B
$0
$2.7B
Q4 24
$2.6B
$0
$2.6B
Q1 25
$2.5B
$0
$2.5B
Q2 25
$2.8B
$0
$2.8B
Q3 25
$4.0B
$0
$4.0B
Q4 25
$4.5B
$0
$4.5B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
104M
+0.4%
Q2 23
105M
+0.4%
Q3 23
107M
+2.2%
Q4 23
104M
-2.7%
Q1 24
104M
+0.2%
Q2 24
105M
+0.4%
Q3 24
105M
+0.0%
Q4 24
106M
+1.5%
Q1 25
111M
+4.6%
Q2 25
113M
+1.5%
Q3 25
115M
+1.5%
Q4 25
113M
-0.9%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
—
—
FY 15
$37K
240
FY 16
$3K
348
FY 17
$265K
900
FY 18
$90K
2K
FY 19
$122K
4K
FY 20
$58K
5K
FY 21
$143K
8K
FY 22
$154K
9K
FY 23
$232K
11K
FY 24
$346K
11K
FY 25
$445K
12K
marketcaparena.com